Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenfei Fang

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
BMJ Open|November 21, 2023
Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement: protocol for a multicentre, open-label, randomised controlled clinical trialXiangming Hu, Haiyan Xu, Can Wang, et al.
Heart (British Cardiac Society)|May 28, 2026
Effect of renin-angiotensin system inhibition on left ventricular mass regression after transcatheter aortic valve replacement: a randomised controlled trialRuochen Shao, Fang-Yang Huang, Yanbiao Liao, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2026
Drug-Coated Balloons Versus Drug-Eluting Stents for Patients With Long De Novo Coronary Artery Lesions: Insights From the REC-CAGEFREE I TrialYuehao Lv, Feng Yang, Xiongwei Bai, et al.
JACC. Cardiovascular Interventions|March 26, 2026
Drug-Coated Balloon Angioplasty vs Drug-Eluting Stents in Noncomplex Coronary Bifurcation Lesions: The REC-CAGEFREE I TrialBin Zhu, Fei Li, Jianzheng Liu, et al.
Cardiovascular Therapeutics|September 3, 2020
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19Shi Tai, Jianjun Tang, Bilian Yu, et al.
Journal of the American College of Cardiology|November 6, 2025
Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I TrialLing Tao, Xingqiang He, Guidong Shen, et al.
International Journal of Cardiology|August 19, 2025
Safety and efficacy of transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type 0 bicuspid aortic valve stenosis patientsDejing Feng, Moyang Wang, Jian'an Wang, et al.
Lancet (London, England)|September 5, 2024
Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trialChao Gao, Xingqiang He, Fan Ouyang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 23, 2024
Safety and efficacy of the DragonFly system for transcatheter valve repair of degenerative mitral regurgitation: one-year results of the DRAGONFLY-DMR trialJian'an Wang, Xianbao Liu, Zhaoxia Pu, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
BMJ Open|November 21, 2023
Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement: protocol for a multicentre, open-label, randomised controlled clinical trialXiangming Hu, Haiyan Xu, Can Wang, et al.
Heart (British Cardiac Society)|May 28, 2026
Effect of renin-angiotensin system inhibition on left ventricular mass regression after transcatheter aortic valve replacement: a randomised controlled trialRuochen Shao, Fang-Yang Huang, Yanbiao Liao, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2026
Drug-Coated Balloons Versus Drug-Eluting Stents for Patients With Long De Novo Coronary Artery Lesions: Insights From the REC-CAGEFREE I TrialYuehao Lv, Feng Yang, Xiongwei Bai, et al.
JACC. Cardiovascular Interventions|March 26, 2026
Drug-Coated Balloon Angioplasty vs Drug-Eluting Stents in Noncomplex Coronary Bifurcation Lesions: The REC-CAGEFREE I TrialBin Zhu, Fei Li, Jianzheng Liu, et al.
Cardiovascular Therapeutics|September 3, 2020
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19Shi Tai, Jianjun Tang, Bilian Yu, et al.
Journal of the American College of Cardiology|November 6, 2025
Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I TrialLing Tao, Xingqiang He, Guidong Shen, et al.
International Journal of Cardiology|August 19, 2025
Safety and efficacy of transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type 0 bicuspid aortic valve stenosis patientsDejing Feng, Moyang Wang, Jian'an Wang, et al.
Lancet (London, England)|September 5, 2024
Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trialChao Gao, Xingqiang He, Fan Ouyang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 23, 2024
Safety and efficacy of the DragonFly system for transcatheter valve repair of degenerative mitral regurgitation: one-year results of the DRAGONFLY-DMR trialJian'an Wang, Xianbao Liu, Zhaoxia Pu, et al.
Pageof 7